
Loading, please wait...

Loading, please wait...

Recent research highlights significant concerns regarding 2-Ethyl-1-hexanol health effects following chronic inhalation. 2-Ethyl-1-hexanol (2EH) is a common volatile organic compound (VOC). It often originates from the hydrolysis of flooring materials in buildings. While previous studies focused on short-term exposure, a new study demonstrates that even low concentrations can cause lasting damage. Specifically, researchers observed histopathological changes at levels as low as 0.5 ppm over a six-month period.
The study utilized male ICR mice to examine the impact of 2EH at various concentrations. These mice were exposed for eight hours daily, five days a week. At the lowest tested concentration of 0.5 ppm, the researchers identified acute and chronic inflammation. This inflammation primarily affected the olfactory epithelium and the pulmonary alveoli. Furthermore, the researchers noted tissue thickening in the bronchi and epithelial repair in the nose. These findings suggest that current safety thresholds may need re-evaluation for long-term indoor air quality.
In addition to respiratory issues, the study revealed significant neurological and dermatological impacts. Chronic exposure led to a decrease in mature neurons within the olfactory epithelium. It also reduced immature neurons in the olfactory bulb. This suggests a suppression of olfactory nerve activity. Moreover, the study reported an increase in microglia within the hippocampus and amygdala. These brain regions are critical for memory and emotional processing. Consequently, prolonged exposure to 2EH might contribute to the cognitive symptoms often reported in sick building syndrome.
Furthermore, the skin is not immune to these toxic effects. The researchers observed an increase in fibroblasts in the dorsal skin across all exposure levels. This indicates a systemic response to the inhaled VOC. Because 2EH can be released from flooring for over a decade, these results emphasize the importance of monitoring indoor air pollutants. Clinicians should consider environmental exposures when patients present with persistent respiratory or neurological complaints.
2-Ethyl-1-hexanol is a volatile organic compound often released from flooring materials, adhesives, and plasticizers through hydrolysis. It is a major contributor to sick building syndrome.
Even at 0.5 ppm, chronic exposure can increase microglial cells in the hippocampus and amygdala. It also suppresses olfactory neuron activity, potentially impacting sensory and cognitive functions.
Yes, research shows that chronic inhalation of 2EH can lead to an increase in skin fibroblasts, suggesting that the compound\'s effects are not limited to the respiratory tract.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional diagnosis. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Wakayama T et al. Chronic inhalation exposure to 0.5 ppm of 2-ethyl-1-hexanol induces histopathological changes in olfactory, respiratory, and skin tissue of mice. J Occup Health. 2026 Mar 23. doi: undefined. PMID: 41870494.
Norbäck D et al. Volatile organic compounds and personal factors related to sick building syndrome. Brit J Ind Med. 1990;47(11):733-741.
Miyake M et al. Subchronic inhalation exposure to 2-ethyl-1-hexanol impairs the mouse olfactory bulb. Arch Toxicol. 2016;90(8):1949-1958.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A recent study shows that 0.5 ppm of 2-ethyl-1-hexanol causes chronic inflammation in respiratory and skin tissues, as well as neurological changes in mice....
5 months ago

A comparative analysis shows that older age, elevated blood glucose, and abdominal adiposity are primary drivers of hypertension. Comprehensive evaluation of cardiometabolic risk profiles enables clinicians to detect overlapping metabolic dysfunctions early and optimize targeted prevention strategies.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Left ventricular thrombus is a severe complication of acute decompensated heart failure. This clinical review explores the pathophysiology, imaging challenges, and pharmacotherapeutic considerations of laminated thrombi, evaluating the evolving role of direct oral anticoagulants versus traditional warfarin.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today